Skip to content
Menu
Home
about AesMed
AesMed Story
AGF39
Cytokine Therapy for Inhibition of DHT-Induced Hair Loss and Normalization of the Anagen Phase
2025-04-25
How AesMed’s AGF39™ Supports Hair Regeneration Hair loss is a common issue affecting ...
Read More
Latest Posts
CytoMesopecia – Cytokines Mesotherapy for Alopecia (Part 1)
AesMed Expands Its Mission Through an Official MOU With the Korean Alopecia Areata Patients Association
AesMed Successfully Exhibits at Cosmoprof Asia 2025
Mesotherapy for Alopecia (Part 3) AesMed’s Innovation and Future Vision
AesMed to Exhibit at Cosmoprof Asia 2025 in Hong Kong
1111 Hair Care Day Campaign 2025 – Global Initiative in Korea, Japan & Malaysia
Hair Care Day 2025 Campaign Officially Begins!
Mesotherapy for Alopecia (Part 2)
Mesotherapy for Alopecia (Part 1)
Hair Care Day campaign– Purpose, History, Mission, and Vision
Search for:
